Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lexaria Bioscience Corp (NQ: LEXX ) 2.700 +0.060 (+2.27%) Streaming Delayed Price Updated: 9:50 AM EDT, Jul 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Lexaria Bioscience Corp < Previous 1 2 ... 16 17 18 19 20 21 22 23 Next > CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Proprietary Technology Elevating Quantity of Drugs Delivered Across Blood-Brain Barrier by 1,900% September 03, 2021 Via CannabisNewsWire Topics Animal Testing Intellectual Property Exposures Animal Testing COVID-19 Intellectual Property CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology Is ‘Outrageously Fast’ in Oral to Bloodstream Delivery August 27, 2021 Via CannabisNewsWire CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Featured in PCG Report Noting Company Could Deliver for Investors August 17, 2021 Via CannabisNewsWire Topics Intellectual Property Exposures COVID-19 Intellectual Property CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH Provides Potential for Significant Cost Savings to Health Care System August 13, 2021 Via CannabisNewsWire CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Well Positioned to Advance Business, Further Execute on Drug-Delivery Goals August 06, 2021 Via CannabisNewsWire Lexaria Bioscience Corp. (NASDAQ: LEXX) Hails Successful Testing for Effective Transformation of Antivirals for Greater Bioavailability July 29, 2021 Via CannabisNewsWire Lexaria's DehydraTECH-CBD Lowers Blood Pressure July 29, 2021 Human Clinical Study HYPER-H21-1 evidences a rapid and sustained drop in blood pressure with DehydraTECH-CBD and excellent tolerability KELOWNA, BC / ACCESSWIRE / July 29, 2021 / Lexaria Bioscience... From Lexaria Bioscience Corp. Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Product Safety CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reaches Milestone in Human Clinical Study, Notes Growing Availability of DehydraTECH-Enabled Products July 28, 2021 Via CannabisNewsWire Topics Intellectual Property Exposures Intellectual Property DehydraTECH-Enabled Consumer Products Now Available in Over 7,000 Stores July 28, 2021 Lexaria's technology empowers brands nationwide in stores including Albertsons, Hudson News, and many more KELOWNA, BC / ACCESSWIRE / July 28, 2021 / Lexaria Bioscience Corp.... From Lexaria Bioscience Corp. Via AccessWire Topics Intellectual Property Supply Chain Exposures Intellectual Property Supply Chain Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes VIRAL-A20-3 Pharmacokinetic Study on DehydraTECH(TM) Enabled Colchicine July 27, 2021 Via CannabisNewsWire Topics Intellectual Property Exposures Intellectual Property Lexaria Completes Dosing in Human Clinical Study HYPER-H21-2 July 27, 2021 Additionally, second patent award received in Japan KELOWNA, BC / ACCESSWIRE / July 27, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in... From Lexaria Bioscience Corp. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Lexaria Receives US$3,817,643 From Warrant Exercises July 26, 2021 KELOWNA, BC / ACCESSWIRE / July 26, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce the... From Lexaria Bioscience Corp. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Test Results Boost Lexaria Bioscience Corp. (NASDAQ: LEXX) Potential in Enhancing Antiviral Drugs July 23, 2021 Via CannabisNewsWire Exposures COVID-19 CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Results of Antiviral Drug Studies, Strategy Moving Forward July 22, 2021 Via CannabisNewsWire Topics Animal Testing Exposures Animal Testing Lexaria Summarizes Successful Antiviral Drug Studies and Ongoing Strategy July 22, 2021 All objectives evaluating DehydraTECH™ drug delivery platform successfully achieved KELOWNA, BC / ACCESSWIRE / July 22, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or... From Lexaria Bioscience Corp. Via AccessWire Topics Animal Testing Death Intellectual Property Exposures Animal Testing COVID-19 Death CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates Significantly Enhanced Delivery of Colchicine July 21, 2021 Via CannabisNewsWire Lexaria's DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3 July 21, 2021 Possible Benefits for Treating SARS-CoV-2/COVID-19 and mRNA Vaccine Side Effects KELOWNA, BC / ACCESSWIRE / July 21, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or... From Lexaria Bioscience Corp. Via AccessWire Topics Animal Testing Intellectual Property Exposures Animal Testing COVID-19 Intellectual Property CannabisNewsBreaks – Why Lexaria Bioscience Corp. (NASDAQ: LEXX) Is ‘One to Watch’ July 20, 2021 Via CannabisNewsWire New Patent Expands Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Suite to 20 Granted Worldwide (First in Japan) July 16, 2021 Via CannabisNewsWire Topics Intellectual Property Exposures Intellectual Property Lexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada's National Research Council July 15, 2021 VIRAL-MC21-1 Demonstrates Stability of DehydraTECH™-Enabled Antiviral Drugs KELOWNA, BC / ACCESSWIRE / July 15, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"),... From Lexaria Bioscience Corp. Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Considerable IP Portfolio with Patent Protection in Japan July 13, 2021 Via CannabisNewsWire Topics Intellectual Property Exposures Intellectual Property Lexaria Receives Patent Protection in Japan July 13, 2021 New patent granted in Japan adds to existing patents in the EU, the U.S., India and Australia KELOWNA, BC / ACCESSWIRE / July 13, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the... From Lexaria Bioscience Corp. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Lexaria Bioscience Corp. (NASDAQ: LEXX) Delists from CSE to Focus Efforts on Most Effective Drug Platform Outcomes July 12, 2021 Via CannabisNewsWire Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Positive Results From its Recent Animal Study on the Effectiveness of its DehydraTECH Drug Delivery Technology July 08, 2021 Via CannabisNewsWire Lexaria Announces Voluntary Delisting from the Canadian Securities Exchange to Concentrate Trading on the Nasdaq Capital Markets July 05, 2021 KELOWNA, BC / ACCESSWIRE / July 5, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE: LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces that on... From Lexaria Bioscience Corp. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Lexaria Announces 2021 Annual Meeting Results June 29, 2021 KELOWNA, BC / ACCESSWIRE / June 29, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the... From Lexaria Bioscience Corp. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Lexaria Hits Important Anti-Viral Milestone with In Vitro Test of DehydraTECH(TM) June 17, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 Product Safety Lexaria Hits Important Anti-Viral Milestone with In Vitro Test of DehydraTECH(TM) June 17, 2021 New York, New York--(Newsfile Corp. - June 17, 2021) - PCG Digital -- Lexaria Bioscience Corp. (NASDAQ: LEXX) hit a... Via Newsfile Exposures COVID-19 Product Safety Lexaria Drug Delivery Platform Enables up to Three-Fold Increase in Oral Delivery of Antiviral Drugs June 15, 2021 DehydraTECH™ improves delivery into bloodstream of orally administered remdesivir and ebastine in study VIRAL-A20-2 KELOWNA, BC / ACCESSWIRE / June 15, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)... From Lexaria Bioscience Corp. Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Lexaria Provides Progress Report on Six R&D Programs June 09, 2021 - All studies are using DehydraTECH™ 2.0 formulations for multiple market applications, including antivirals, hypertension, NSAIDs and oral nicotine - These studies are part of Lexaria's 2021 applied... From Lexaria Bioscience Corp. Via AccessWire Topics Animal Testing Intellectual Property Exposures Animal Testing COVID-19 Intellectual Property < Previous 1 2 ... 16 17 18 19 20 21 22 23 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
